Correlation Between Immix Biopharma and First Wave
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and First Wave at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and First Wave into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and First Wave BioPharma, you can compare the effects of market volatilities on Immix Biopharma and First Wave and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of First Wave. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and First Wave.
Diversification Opportunities for Immix Biopharma and First Wave
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Immix and First is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and First Wave BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on First Wave BioPharma and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with First Wave. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of First Wave BioPharma has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and First Wave go up and down completely randomly.
Pair Corralation between Immix Biopharma and First Wave
If you would invest 61.00 in First Wave BioPharma on October 6, 2024 and sell it today you would earn a total of 0.00 from holding First Wave BioPharma or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 5.0% |
Values | Daily Returns |
Immix Biopharma vs. First Wave BioPharma
Performance |
Timeline |
Immix Biopharma |
First Wave BioPharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Immix Biopharma and First Wave Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Immix Biopharma and First Wave
The main advantage of trading using opposite Immix Biopharma and First Wave positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, First Wave can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in First Wave will offset losses from the drop in First Wave's long position.Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
First Wave vs. Quoin Pharmaceuticals Ltd | First Wave vs. Revelation Biosciences | First Wave vs. Dermata Therapeutics | First Wave vs. LMF Acquisition Opportunities |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stocks Directory Find actively traded stocks across global markets | |
CEOs Directory Screen CEOs from public companies around the world |